Prostacyclin stimulates embryonic development via regulation of the cAMP response element-binding protein-cyclo-oxygenase-2 signalling pathway in cattle.
Prostacyclin (PGI(2)) in oviducal fluid is synthesised from arachidonic acid by cyclo-oxygenase (COX) and prostacyclin synthetase and enhances the implantation and live birth potential of mouse embryos. In the present study, we investigated the developmental competence of bovine embryos by examining the effects of the PGI(2) analogue iloprost on blastocyst development, quality and COX-2 expression during IVF and somatic cell nuclear transfer (SCNT). Bovine IVF and SCNT embryos were cultured in CR1-aa medium supplemented with 0.3% bovine serum albumin in either the presence or absence of 1 mum iloprost at 38.5 degrees C and 5% CO(2). After 3 days of culture, cleaved embryos were cultured for 4 days in the same medium supplemented with 10% fetal bovine serum. For both IVF and SCNT embryos, iloprost improved the blastocyst developmental rate and cell numbers. In the presence of iloprost, the proportion of expanded blastocysts was significantly higher among the IVF embryos and fewer apoptotic cell nuclei were observed. Expression of COX-2 mRNA and protein, evaluated using real-time polymerase chain reaction and immunoblotting, respectively, was increased in the presence of iloprost. These results suggest that PGI(2) improves the developmental competence of embryos via regulation of the cAMP response element-binding protein-COX-2 signalling pathway in cattle.
Song
Bong-Seok
BS
Center for Regenerative Medicine, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 111 Gwahangno, Yuseong, Daejeon 305-806, Korea.
Kim
Ji-Su
JS
Kim
Cheol-Hee
CH
Han
Yong-Mahn
YM
Lee
Dong-Seok
DS
Lee
Kyung-Kwang
KK
Koo
Deog-Bon
DB
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001755:Blastocyst / Q000187:drug effects / Q000502:physiology; D050882:CREB-Binding Protein / Q000502:physiology*; D002417:Cattle / Q000196:embryology*; D051546:Cyclooxygenase 2 / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000494:pharmacology*; D046149:Embryo Culture Techniques / Q000662:veterinary; D047108:Embryonic Development / Q000187:drug effects*; D005307:Fertilization in Vitro / Q000662:veterinary; D015870:Gene Expression / Q000187:drug effects; D016285:Iloprost / Q000494:pharmacology; D019746:Intramolecular Oxidoreductases / Q000494:pharmacology*; D053652:Nuclear Transfer Techniques / Q000662:veterinary; D012333:RNA, Messenger / Q000032:analysis; D015398:Signal Transduction / Q000187:drug effects*
D012333:RNA, Messenger; D003577:Cytochrome P-450 Enzyme System; D051546:Cyclooxygenase 2; D050882:CREB-Binding Protein; D019746:Intramolecular Oxidoreductases; C022461:prostacyclin synthetase; D016285:Iloprost